Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products

2Firsts Events by 2FIRSTS
Sep.07.2024
Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT CEO Shivam Bihani shares company's journey in nicotine pouch industry, focusing on innovation and global expansion.

On September 6th, Shivam Bihani, the founder and CEO of the Indian nicotine pouch brand MYNT, shared the company's development history, market layout, and future prospects in an interview with 2Firsts. Founded 75 years ago, MYNT has been focusing on research and development and export business of nicotine pouches since entering the oral tobacco market in 2019. The company is committed to improving product taste and user experience through technological innovation.

 

The pharmaceutical background supports the layout of the nicotine pouch market

 

The predecessor of MYNT was a pharmaceutical company, which in 2019 decided to focus its energy on the nicotine pouch field. Shivam Bihani pointed out that the company's pharmaceutical experience has provided a solid foundation for the production and quality control of nicotine pouches, which is also one of the key factors that allow MYNT products to meet the strict standards of the European and American markets. The company's products are currently mainly exported to the European and American markets, as the sale of nicotine pouch products is not allowed in India. The company is optimistic about the potential for global development in the future.

 

MYNT faces strict regulatory requirements for the export of nicotine pouches. Shivam Bihani mentioned that the company had to comply with the FDA's PMTA (Pre-Market Tobacco Product Application) requirements when entering the US market, which not only consumed a significant amount of time and money, but also posed challenges for the company's global expansion. In addition to the US, MYNT also needs to adhere to export qualification restrictions in other countries, further emphasizing the importance of global compliance in the nicotine pouch industry.

 

The company's focus is on the markets in the UK and Malaysia

 

MYNT's nicotine pouch products come in two packaging forms: pouches and boxes, to meet the needs of different consumers. Shivam Bihani emphasizes that through technological innovation, MYNT is able to provide consumers with a better taste experience, which is one of the company's core competitive advantages. Additionally, the company pays attention to the design of the packaging and has obtained relevant patents for protection.

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT bagged products | Image source: 2Firsts

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT box-packaged product | Image source: 2Firsts

 

During the exhibition in Malaysia, MYNT expressed a strong intention to develop global exports. Shivam Bihani revealed that the company's current focus is on the UK and Malaysian markets. He believes that as nicotine pouch products gradually become more popular worldwide, more nicotine users will be able to break the habit of smoking and reduce the health risks associated with traditional tobacco products.

 

Confidence in the Future of Nicotine Pouches

 

Shivam Bihani is confident in the future of nicotine pouches. He believes that despite being a new nicotine product like e-cigarettes, there are significant differences between the two in the market, they are very different. Nicotine pouches are becoming increasingly popular among global consumers due to their smoke-free and convenient characteristics, and they have huge market potential.

 

In regards to the company's development plan, Shivam Bihani stated that the company will continue to focus on the nicotine pouch sector and will not consider expanding into the chewing gum or other compressed product categories. In the future, they will continue to cultivate this market and provide high-quality, safe smokeless nicotine products for consumers worldwide.

 

MYNT's global strategy not only demonstrates the potential of Indian companies in the nicotine pouch field, but also provides new ideas for the global development of the nicotine pouch industry.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles authorities searched 12 businesses and arrested 24 people during a multi-agency operation targeting illicit flavored vaping products, flavored cigarettes and counterfeit merchandise on October 22, 2026. The Los Angeles County Sheriff's Department said approximately eight tractor-trailer loads of merchandise were seized. Alleged violations involved flavored tobacco sales restrictions, tobacco licensing requirements and counterfeit trademark laws. Local, state and federal agencies participated. Authorities have not disclosed the number, brands or value of vaping products seized. Investigations remain ongoing.
Enforcement
Oct.28
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives